Business Description
Pfizer Ltd
NAICS : 325412
ISIN : INE182A01018
Share Class Description:
NSE:PFIZER: Shs DematerialisedCompare
Compare
Traded in other countries / regions
PFIZER.India IPO Date
1999-04-28Description
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.45 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.15 | |||||
| Interest Coverage | 50.3 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 17.2 | |||||
| Beneish M-Score | -2.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | 7.6 | |||||
| 3-Year EPS without NRI Growth Rate | 7.3 | |||||
| 3-Year FCF Growth Rate | -1.7 | |||||
| 3-Year Book Growth Rate | -1.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.79 | |||||
| 9-Day RSI | 39.33 | |||||
| 14-Day RSI | 39.56 | |||||
| 6-1 Month Momentum % | 10.69 | |||||
| 12-1 Month Momentum % | 14.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.15 | |||||
| Quick Ratio | 3.5 | |||||
| Cash Ratio | 3.11 | |||||
| Days Inventory | 189.11 | |||||
| Days Sales Outstanding | 26.49 | |||||
| Days Payable | 96.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.84 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 42.4 | |||||
| Forward Dividend Yield % | 2.41 | |||||
| 5-Year Yield-on-Cost % | 2.53 | |||||
| Shareholder Yield % | 1.03 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.08 | |||||
| Operating Margin % | 24.91 | |||||
| Net Margin % | 22.63 | |||||
| FCF Margin % | 13.1 | |||||
| ROE % | 16.03 | |||||
| ROA % | 12.73 | |||||
| ROIC % | 23.46 | |||||
| ROC (Joel Greenblatt) % | 308.75 | |||||
| ROCE % | 20.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.83 | |||||
| PE Ratio without NRI | 37.12 | |||||
| Shiller PE Ratio | 36.36 | |||||
| Price-to-Owner-Earnings | 24.89 | |||||
| PEG Ratio | 4.47 | |||||
| PS Ratio | 8.56 | |||||
| PB Ratio | 5.8 | |||||
| Price-to-Tangible-Book | 7.01 | |||||
| Price-to-Free-Cash-Flow | 65.34 | |||||
| Price-to-Operating-Cash-Flow | 53.4 | |||||
| EV-to-EBIT | 25.36 | |||||
| EV-to-EBITDA | 22.83 | |||||
| EV-to-Revenue | 7.74 | |||||
| EV-to-FCF | 59.04 | |||||
| Price-to-Projected-FCF | 3.11 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Price-to-Graham-Number | 3.32 | |||||
| Price-to-Net-Current-Asset-Value | 10.45 | |||||
| Price-to-Net-Cash | 16.15 | |||||
| Earnings Yield (Greenblatt) % | 3.94 | |||||
| FCF Yield % | 1.53 | |||||
| Forward Rate of Return (Yacktman) % | 10.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pfizer Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 22,191.8 | ||
| EPS (TTM) (₹) | 109.76 | ||
| Beta | 0.32 | ||
| Volatility % | 16.13 | ||
| 14-Day RSI | 39.56 | ||
| 14-Day ATR (₹) | 110.136984 | ||
| 20-Day SMA (₹) | 4218.04 | ||
| 12-1 Month Momentum % | 14.5 | ||
| 52-Week Range (₹) | 3690 - 5000 | ||
| Shares Outstanding (Mil) | 45.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pfizer Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pfizer Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pfizer Ltd Frequently Asked Questions
What is Pfizer Ltd(NSE:PFIZER)'s stock price today?
The current price of NSE:PFIZER is ₹4148.70. The 52 week high of NSE:PFIZER is ₹5000.00 and 52 week low is ₹3690.00.
When is next earnings date of Pfizer Ltd(NSE:PFIZER)?
The next earnings date of Pfizer Ltd(NSE:PFIZER) is .
Does Pfizer Ltd(NSE:PFIZER) pay dividends? If so, how much?
The Dividend Yield %  of Pfizer Ltd(NSE:PFIZER) is 0.84% (As of Today), Highest Dividend Payout Ratio of Pfizer Ltd(NSE:PFIZER) was 0.5. The lowest was 0.09. And the median was 0.21. The  Forward Dividend Yield % of Pfizer Ltd(NSE:PFIZER) is 2.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers